Frontlight ResearchEarly access
CompletedNo phase
A Study to Evaluate the Safety and Efficacy of Eye Secret UV Aspheric Silicone Soft (Hydrophilic) 1Day Color Contact Lens
Key facts
- Who runs it
- Yung Sheng Optical Co., Ltd.
- Where
- Taiwan3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 131 people enrolled
- Started
- 13 Feb 2023
- Ended
- 30 Nov 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- soft contact lens
- Record updated
- 24 January 2025
Who can take part
- Age
- 20 years to 25 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age from 20 to 65
- Subject with -1.00 to -10.00 D myopia, less than 1.00 D astigmatism
- Subjects must be correctable through spherocylindrical refraction and with soft contact lenses to 0 Log MAR (distance) or better in each eye
- Willing to comply with all study procedures and be available for the study duration
- Provide signed and dated informed consent form
Who cannot take part
- Subjects have medications that would contraindicate contact lens wear
- Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
- Any active participation in any contact lens or lens care product clinical trial within seven days prior to this study
- Subject had any corneal surgery (e.g., refractive surgery)
- Subjects have a history of allergies that contraindicate contact lens wear
- Subjects have other active ocular or systemic diseases such as, but not limited to anterior uveitis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermas, keratoconus or diabetes
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures
- Subject has a known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates or fungal infections
- Subject has a history of papillary conjunctivitis that has interfered with contact lens wear
- Subject has a history of herpetic keratitis retinal detachment or irregular cornea
- Subject has a history of recurrent eye or eyelid infections, adverse effects associated with your contact lens wear, intolerance or unusual response to your contact lens wear
- The subject has over grade II corneal and conjunctival staining (Oxford scheme) if who has a history of dry eye
- Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next 3 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This was a prospective, randomized, open label, parallel, active-controlled clinical study to assess the safety and efficacy of Silicone Color Contact Lens for vision correction.
The 2 groups in the trial
- Si-Hy (Otufilcon A)Treatment being tested
Treatment: soft contact lens
- Si-Hy soft contact lensExisting treatment, for comparison
Treatment: soft contact lens
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 January 2025